Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.
The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Antisense and RNAi Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Antisense and RNAi Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Antisense and RNAi Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Isis Pharmaceuticals
Alnylam Pharmaceuticals
Tekmira Pharmaceuticals
Antisense Therapeutics
Roche
Silence Therapeutics
Santaris
Sirnaomics
Arbutus Biopharma
By Type:
RNA Interference
Antisense RNA
By End-User:
Hospital
Clinic
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antisense and RNAi Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2016 to 2027
-
1.3.2 China Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antisense and RNAi Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antisense and RNAi Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of RNA Interference
-
3.4.2 Market Size and Growth Rate of Antisense RNA
4 Segmentation of Antisense and RNAi Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antisense and RNAi Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Hospital
-
4.4.2 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Clinic
5 Market Analysis by Regions
-
5.1 China Antisense and RNAi Therapeutics Production Analysis by Regions
-
5.2 China Antisense and RNAi Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Antisense and RNAi Therapeutics Landscape Analysis
-
6.1 North China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
6.2 North China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
7 Central China Antisense and RNAi Therapeutics Landscape Analysis
-
7.1 Central China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
8 South China Antisense and RNAi Therapeutics Landscape Analysis
-
8.1 South China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
8.2 South China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
9 East China Antisense and RNAi Therapeutics Landscape Analysis
-
9.1 East China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
9.2 East China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Antisense and RNAi Therapeutics Landscape Analysis
-
10.1 Northeast China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Antisense and RNAi Therapeutics Landscape Analysis
-
11.1 Southwest China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Antisense and RNAi Therapeutics Landscape Analysis
-
12.1 Northwest China Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Isis Pharmaceuticals
-
13.1.1 Isis Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Alnylam Pharmaceuticals
-
13.2.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Tekmira Pharmaceuticals
-
13.3.1 Tekmira Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Antisense Therapeutics
-
13.4.1 Antisense Therapeutics Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Roche
-
13.5.1 Roche Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Silence Therapeutics
-
13.6.1 Silence Therapeutics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Santaris
-
13.7.1 Santaris Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sirnaomics
-
13.8.1 Sirnaomics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Arbutus Biopharma
-
13.9.1 Arbutus Biopharma Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2016 to 2027
-
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antisense and RNAi Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antisense and RNAi Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antisense and RNAi Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Antisense and RNAi Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of RNA Interference
-
Figure Market Size and Growth Rate of Antisense RNA
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antisense and RNAi Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antisense and RNAi Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Table China Antisense and RNAi Therapeutics Production by Regions
-
Table China Antisense and RNAi Therapeutics Production Share by Regions
-
Figure China Antisense and RNAi Therapeutics Production Share by Regions in 2016
-
Figure China Antisense and RNAi Therapeutics Production Share by Regions in 2021
-
Figure China Antisense and RNAi Therapeutics Production Share by Regions in 2027
-
Table China Antisense and RNAi Therapeutics Consumption by Regions
-
Table China Antisense and RNAi Therapeutics Consumption Share by Regions
-
Figure China Antisense and RNAi Therapeutics Consumption Share by Regions in 2016
-
Figure China Antisense and RNAi Therapeutics Consumption Share by Regions in 2021
-
Figure China Antisense and RNAi Therapeutics Consumption Share by Regions in 2027
-
Table North China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table North China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table Central China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table South China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table South China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table East China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table East China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Antisense and RNAi Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Antisense and RNAi Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Antisense and RNAi Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Antisense and RNAi Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Antisense and RNAi Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Isis Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Isis Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Isis Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Isis Pharmaceuticals
-
Table Product and Service Introduction of Isis Pharmaceuticals
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
Table Company Profile and Development Status of Tekmira Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals
-
Table Product and Service Introduction of Tekmira Pharmaceuticals
-
Table Company Profile and Development Status of Antisense Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisense Therapeutics
-
Figure Sales and Growth Rate Analysis of Antisense Therapeutics
-
Figure Revenue and Market Share Analysis of Antisense Therapeutics
-
Table Product and Service Introduction of Antisense Therapeutics
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Silence Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics
-
Figure Sales and Growth Rate Analysis of Silence Therapeutics
-
Figure Revenue and Market Share Analysis of Silence Therapeutics
-
Table Product and Service Introduction of Silence Therapeutics
-
Table Company Profile and Development Status of Santaris
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santaris
-
Figure Sales and Growth Rate Analysis of Santaris
-
Figure Revenue and Market Share Analysis of Santaris
-
Table Product and Service Introduction of Santaris
-
Table Company Profile and Development Status of Sirnaomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics
-
Figure Sales and Growth Rate Analysis of Sirnaomics
-
Figure Revenue and Market Share Analysis of Sirnaomics
-
Table Product and Service Introduction of Sirnaomics
-
Table Company Profile and Development Status of Arbutus Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma
-
Figure Sales and Growth Rate Analysis of Arbutus Biopharma
-
Figure Revenue and Market Share Analysis of Arbutus Biopharma
-
Table Product and Service Introduction of Arbutus Biopharma
-
